Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
- Gene drive systems
-
2. Different types of gene drives
- Prof. Jackson Champer
-
3. Population modification of malaria vector mosquitoes
- Dr. Anthony A. James
-
5. CRISPR-based suppression drives for vector control
- Prof. Andrea Crisanti
- Active genetics and drive effector factors
-
8. The dawn of active genetics
- Prof. Ethan Bier
-
10. Ecological considerations for gene drive systems
- Prof. Gregory C. Lanzaro
- Mathematical modeling
-
12. Gene drive behavior when pest populations have age, mating and spatial structure
- Prof. Fred Gould
- Prof. Alun Lloyd
- Social and ethical considerations
-
13. The risks and benefits of gene drive technology
- Prof. Henry Greely
-
14. Guidance for responsible testing and implementation of gene-drive systems
- Prof. Stephanie James
-
16. CRISPR editing therapy for Duchenne Muscular Dystrophy 1
- Prof. Dongsheng Duan
-
17. CRISPR editing therapy for Duchenne Muscular Dystrophy 2
- Prof. Dongsheng Duan
Printable Handouts
Navigable Slide Index
- Introduction
- What is malaria?
- What should we know about malaria parasites?
- What should we know about mosquitoes?
- What are we doing about malaria?
- What are the genetic control objectives?
- What are the major research areas?
- What is the experimental system?
- Who conceived population modification?
- What are benefits of population modification?
- How do we achieve population modification?
- How are genes made and introduced?
- What is the strategy for attacking malaria?
- What genes provide control DNA?
- What are the malaria-resistance genes?
- Compartment-specific expression
- How are the experiments done?
- Results of parasite challenge experiments
- How can beneficial genes be used?
- What is gene drive?
- What are the genetics of gene drive?
- Drive mechanism & drive system
- The CRISPR/Cas 9 system (1)
- The CRISPR/Cas 9 system (2)
- The CRISPR/Cas 9 system (3)
- What are advantages of Cas9 system?
- What are the features of this system?
- How does it work and what are the outcomes?
- Male lineage outcrosses
- Female lineage outcrosses
- What will it take to make it happen?
- Genetics-based vector control pipeline
- Phase trials
- What are the take-home messages?
- Eradication
- Acknowledgements
Topics Covered
- Synthetic genes added to mosquitoes suppress transmission of malaria parasites
- Cas9-based gene drive for spreading supressive genes into mosquito populations
- Gene driven strains and their role in sustaining malaria control and eradication
- Novel regulatory and community engagement activities prior to field use of modified mosquitoes
Talk Citation
James, A.A. (2018, April 30). Population modification of malaria vector mosquitoes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ALBT8843.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Anthony A. James has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Genetics & Epigenetics
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Anthony James.
The title of the talk is Population Modification of Malaria Vector Mosquitoes.
I'm in the Department of Microbiology and Molecular Genetics and
Molecular Biology and Biochemistry at the University of California Irvine.
0:15
What I'm going to be doing today is
introducing the problem that we're going to be talking about,
outlining some potential solutions and at the end,
talk about moving ahead.
So the first question we have is, what is malaria?
Malaria, as an infectious disease,
it's something that you patch and is caused by an intracellular protozoan parasite.
The image that we have here is a blood smear of human red blood cells.
For those of you taking Human Anatomy,
you recognize that these cells should be empty.
What we see here are little purple inclusions,
which represent the malaria parasites.
Malaria is a mosquito-borne disease.
It's transmitted by members of the genus Anopheles.
We have an image here of Anopheles.
It can be female feeding on someone's arm.
There's a high degree of whole specificity of a malaria parasite.
We find that there are malaria parasites that will infect humans,
and we find malaria parasites for example that will infect mice.
Human parasites will not cause disease in
mice and mice parasites will not cause disease in humans.
This will be important for us later on.
The other thing that's significant is there are no free living forms of the parasite.
We know where they are. They're either in
the mosquitoes or they're in the vertebrate hosts.
In the case of human malaria parasites,
of course, those are human beings.
1:32
So what should we know about malaria?
Well, this image here is quite complex and
indeed the title says that there is a complex lifecycle,
and there are stages of development both in the mosquito which is
called the sporogonic cycle and also with the human being.
At this point, it's not important to memorize these various stages,
but I will point out that we'll be talking about
the parasite stages that are on the left side of the image here,
the sporogonic cycle in the mosquito.
What happens is a mosquito bites an infected human, takes up parasites,
and they go through a number of developmental stages to the point
where they are able then to be transmitted onto a new human host.